Dermatological cream formulated for skin affected by wearable electronics

The dermatological cream addresses skin issues from wearable devices with a targeted formulation of encapsulated active ingredients, providing immediate relief and ongoing protection through hydration, anti-inflammatory, and antimicrobial actions, suitable for various forms and user needs.

WO2025174368A1PCT designated stage Publication Date: 2025-08-21SONENBLICK JAACOV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/015875
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-02-14
Publication Date
2025-08-21

AI Technical Summary

Technical Problem

Existing dermatological creams are ineffective in addressing skin problems caused by the prolonged wear of wearable technology devices such as smartwatches and fitness trackers, failing to provide targeted relief from friction, pressure, sweat accumulation, and allergic reactions.

Method used

A dermatological cream formulated with encapsulated active ingredients, plant-derived moisturizers, natural anti-inflammatory and antimicrobial agents, and a novel cooling component, designed in various forms (cream, lotion, gel, serum, spray, and patch) to provide immediate relief and ongoing protection for skin irritations and allergies induced by wearable devices.

Benefits of technology

The cream effectively hydrates, soothes, protects, and heals skin irritations and allergies caused by wearable technology, maintaining skin health and comfort through a synergistic combination of hydration, anti-inflammatory, and antimicrobial effects, tailored for specific skin conditions and user preferences.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

According to one aspect of the present invention disclosed herein, there is provided a topical dermatologic cream for treating wearable technology-induced skin irritation, comprising: one or more hydrating agents; one or more anti-inflammatory agents; one or more antimicrobial agents; one or more barrier-forming agents; one or more cooling and soothing agents; one or more texture enhancers and stabilizers; one or more preservatives; and one or more pH adjusters. According to another aspect, there is provided a method of treating wearable technology-induced skin irritation, comprising: determining an area of the body of a person on which a wearable device has been in contact; and applying a dermatologic cream to an area of the body of a person on which a wearable device has been in contact.
Need to check novelty before this filing date? Find Prior Art

Description

TITLEDERMATOLOGICAL CREAM FORMULATED FOR SKIN AFFECTED BYWEARABLE ELECTRONICSBackground

[0001] Dermatological creams have been described in the prior art patent literature.

[0002] For example, US8980228 describes compositions and methods, e.g. a formulation comprising low molecular weight hyaluronic acid and perfluorocarbons ofvarious molecular weights and a method of using it to treat damaged skin.

[0003] KR20080026924 discloses composition comprising a low molecular weight hyaluronic acid is provided to show moisturizing, wrinkle improving, wound healing and anti-inflammatory effects and be permeated into skin more easily than a high molecular weight hyaluronic acid. The composition is in the form of a skin external application composition such as cream, gel, patch, spray, ointment, plaster, lotion, liniment, paste type or cataplasma, or a cosmetic composition such as skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutritive lotion, massage cream, nutritive cream, moisture cream, hand cream, foundation, essence, nutritive essence, pack, soap, cleansing foam, cleansing lotion, cleaning cream, body lotion or body cleanser..

[0004] However, prior art dermatological creams have not been formulated to ameliorate skin problems caused by use of wearable electronic devices and are lacking in effectiveness for that purpose.Summary of Invention

[0005] Therefore, the present invention is a dermatological cream formulated to address and mitigate the adverse skin reactions caused by the prolonged wear of wearable technology devices, such as smartwatches and fitness trackers.

[0006] This topical solution uniquely combines encapsulated active ingredients, plant-derived moisturizers, natural anti-inflammatory and antimicrobial agents, and a novel cooling component to provide immediate relief, ongoing protection, and healing for skin irritations and allergies induced by wearable devices.

[0007] The cream's formulation is designed to be gentle on the skin, suitable for daily use, and effective in maintaining skin health and comfort for wearable technology users.

[0008] According to one aspect of the present invention disclosed herein, there is provided a topical dermatologic cream for treating wearable technology- induced skin irritation, comprising: one or more hydrating agents; one or more anti-inflammatory agents; one or more antimicrobial agents; one or more barrier-forming agents; one or more cooling and soothing agents; one or more texture enhancers and stabilizers; one or more preservatives; and one or more pH adjusters.

[0009] According to another aspect, there is provided a method of treating wearable technology-induced skin irritation, comprising: determining an area of the body of a person on which a wearable device has been in contact; and applying a dermatologic cream to an area of the body of a person on which a wearable device has been in contact.Detailed Description

[0010] The invention addresses the growing problem of skin irritations, rashes, and allergic reactions resulting from continuous contact with wearable technology. Users of smartwatches and fitness trackers often experience discomfort due to friction, pressure, sweat accumulation, and allergic responses to materials used in wearable devices. Existing skincare and topical treatment products do not specifically target the unique combination of factors contributing to wearable-induced skin conditions. This invention solves this problem by providing a targeted, effective, and comprehensive solution that hydrates, soothes, protects, and heals the skin, focusing on the specific challenges posed by wearable technology.

[0011] The present invention can take the form of various dermatological preparations.

[0012] a. Cream Form:

[0013] - Specifically designed for rich, emollient hydration, ideal for deep moisturizing needs and for areas experiencing severe dryness or irritation from wearables. This form includes, but is not limited to, a higher concentration of barrier-forming agents and hydrating agents to provide a sustained release of moisture and protection throughout the day or night.

[0014] b. Lotion Form:

[0015] - A lighter alternative to creams, containing, but not limited to, a balanced mix of hydrating and soothing agents that offer quick absorption and hydration without leaving a heavy residue. Suitable for general application or for userswho prefer a less intense moisture treatment, facilitating use under clothing or alongside wearable devices.

[0016] c. Gel Form:

[0017] - Comprising, but not limited to, cooling and soothing agents like natural menthol derivatives and cucumber extract, providing an immediate cooling effect ideal for soothing irritated skin quickly. The gel form is alcohol-free to prevent drying, making it perfect for use on skin irritated by sweat accumulation under wearables.

[0018] d. Serum Form:

[0019] - A concentrated formula including, but not limited to, high-potency anti- inflammatory and antimicrobial agents targeted for specific problem areas where wearables cause localized irritation. Designed for pinpoint application, serums offer quick penetration and rapid relief from symptoms.

[0020] e. Spray Form:

[0021] - Incorporating, but not limited to, a lightweight mixture of hydrating, soothing, and antimicrobial agents in a liquid form that can be easily sprayed over large or hard-to-reach areas. This form is designed for convenience, allowing for even coverage and fast application without the need for rubbing or spreading, ideal for sensitive or freshly irritated skin.

[0022] f. Patch Form:

[0023] - Consisting of, but not limited to, an advanced delivery system that enables sustained release of active ingredients directly to the area of concern.Patches are particularly useful for continuous treatment of localized issues,providing a barrier to further irritation from wearables while treating the underlying condition with a concentrated dose of therapeutic agents.

[0024] 4.1. Each application form of the dermatological composition is developed with, but not limited to, specific ratios of active ingredients optimized for the form's unique delivery mechanism, ensuring that the therapeutic benefits are consistent across all forms while tailored to the specific needs and preferences of the user.

[0025] 4.2. The adaptability in form selection is guided by, but not limited to, considerations such as the severity and type of skin condition, the area of the body affected by wearables, the user's lifestyle and preferences, and the environmental conditions to which the skin is exposed, ensuring a personalized approach to treatment and prevention of wearable-induced skin conditions.

[0026] The dermatological composition is meticulously engineered to be adaptable for application in a multitude of forms, existing and yet to be developed, each selected to optimize the therapeutic efficacy for various skin conditions induced or exacerbated by wearable items. This adaptability caters to user preferences for application ease and sensory experience, ensuring broad coverage and inclusivity. The composition comprises, but is not limited to:

[0027] a. Current Application Forms: Including cream, lotion, gel, serum, spray, and patch forms, each developed with specific ratios of active ingredients optimized for the form’s unique delivery mechanism. These forms are chosen for their ability to provide sustained release of moisture, targeted relief, and protection in areas affected by wearables.

[0028] b. Future Application Forms and Methodologies: The scope of this claim explicitly includes any innovative or yet-to-be-invented application forms and methodologies that achieve the therapeutic objectives of the dermatological composition. This future-proofing clause is intended to encompass advancements in technology, application techniques, and user interaction models that enhance the delivery, efficacy, or user experience of the composition for treating conditions related to wearable technology use.

[0029] Personalized and Adaptive Application: The composition's adaptability extends to personalized treatment plans and application methods based on individual user data, including but not limited to skin type, severity of condition , lifestyle factors, and environmental exposure. This approach ensures that as new diagnostic and application technologies emerge, the composition remains at the forefront of personalized dermatological care.

[0030] The present invention is designed to cover not only the known application forms but also any advancements or innovations in the field of dermatological treatment application methods. It is designed to systematically address, treat, and prevent skin conditions resulting from or exacerbated by the contact with wearable items, through a detailed regimen that includes:

[0031] a. Assessment Phase: Initiating with a thorough evaluation of the skin to identify areas affected by or vulnerable to irritation and other conditions due to wearable items. This includes, but is not limited to, visual examination for signs of redness, inflammation, dry patches, and any discomfort reported by the user. Special attention is given to commonly affected areas like the wrist under smartwatches, the chest area where fitness trackers are worn, and any regions subjected to prolonged pressure or friction.

[0032] b. Selection of Appropriate Form: Based on the assessment, choosing the most suitable form of the dermatological composition (cream, lotion, gel, serum, spray, or patch) that aligns with the specific condition, location, and severity of the skin issue. This decision is informed by, but not limited to, considerations such as the need for deep hydration, immediate cooling relief, targeted treatment, or sustained release of active ingredients.

[0033] c. Application Guidelines: Providing detailed instructions for applying the selected form of the composition to the affected or at risk areas. This includes, but is not limited to, recommendations on the amount of product to use, techniques for application to maximize absorption and coverage, and advice on the frequency of application to ensure optimal therapeutic efficacy and prevention of further irritation.

[0034] d. Reassessment and Adjustment: Advising on regular reassessment of the skin's condition after the commencement of treatment with the composition. Based on this ongoing evaluation, adjustments may be made to the treatment regimen, including, but not limited to, switching the form of the composition being used, altering the frequency of application, and introducing additional skin care measures to address any changes in the skin condition or response to treatment.

[0035] e. Preventative Measures: In addition to treating existing conditions, the method encompasses preventative application strategies for individuals frequently using wearable items. This includes, but is not limited to, applying a protective layer of the composition to areas of the skin before wearable contact, particularly in situations of anticipated prolonged wear or exposure to conditions likely to exacerbate skin issues.

[0036] The method emphasizes personalized treatment plans tailored to the individual's specific skin type, wearable usage patterns, and lifestyle factors, ensuring the dermatological composition is used in a manner that maximizes its therapeutic benefits while preventing potential skin issues related to wearables.

[0037] Education on skin care hygiene and maintenance for wearable users is also included, providing comprehensive guidelines on cleaning both the skin and the wearable items to reduce the risk of irritation and enhance the overall effectiveness of the dermatological treatment regimen.

[0038] Dermatologic preparations of the present invention include HydratingAgents, Anti-inflammatory Agents, Antimicrobial Agents, Barrier-FormingAgents, Cooling and Soothing Agents, Texture Enhancers and Stabilizers, and Preservatives and pH Adjusters.

[0039] Hydrating Agents

[0040] Purpose: To provide moisture to the skin, preventing dryness and maintaining the skin's barrier function. This category specifically includes, but is not limited to, encapsulated hyaluronic acid microspheres that ensure deep and sustained skin hydration through controlled release, glycerin known for its humectant properties that attract moisture to the skin, and squalane, a plant- derived oil that closely mimics the skin’s own natural oils, providing hydration without leaving a greasy residue. These agents are selected for their unique properties to penetrate different layers of the skin, offering hydration that is both immediate and long-lasting.

[0041] Preferred Examples: Encapsulated hyaluronic acid microspheres for deep hydration, glycerin, and natural oils like squalane that mimic the skin's natural moisturizing factors.

[0042] Other Examples:

[0043] Encapsulated Hyaluronic Acid Microspheres, Glycerin, Squalane,Polyethylene Glycol (PEG) derivatives, Aloe Vera Gel, Honey, Sodium PCA,Propylene Glycol, Butylene Glycol, Urea, Panthenol (Provitamin B5).

[0044] Anti-inflammatory Agents

[0045] Purpose: To reduce inflammation and soothe irritated skin, crucial for skin affected by wearables. This includes, but is not limited to, TasmanniaLanceolata extract, valued for its potent antioxidant and anti-inflammatory actions that calm skin irritation and redness; aloe vera, renowned for its soothing and healing properties, particularly in sunburned or inflamed skin; and bisabolol, an active compound derived from chamomile that significantly reduces inflammation and soothes sensitive skin. These ingredients are chosen for their efficacy in reducing the skin's inflammatory response to irritants and promoting healing.

[0046] Preferred Examples: Tasmannia Lanceolata extract, aloe vera, and bisabolol (from chamomile), known for their soothing and anti-inflammatory properties.

[0047] Other Examples: Tasmannia Lanceolata Extract, Aloe Vera, Bisabolol,Omega Fatty Acids (from fish oil or flaxseed oil), Green Tea Extract, LicoriceRoot Extract, Chamomile Extract, Hydrocortisone (in over-the-counter strengths), Allantoin, Colloidal Oatmeal

[0048] Antimicrobial Agents

[0049] Purpose: To prevent or treat bacterial or fungal skin infections that could be exacerbated by the occlusive environment under wearable devices, and including, but not limited to, liposome-encapsulated tea tree oil, which offers precise delivery of tea tree oil’s antimicrobial benefits without irritating the skin; neem oil, recognized for its extensive antimicrobial properties against a wide range of pathogens; and silver nanoparticles, known for their long-lasting antimicrobial activity. This diverse array of agents is formulated to prevent microbial overgrowth and infections in compromised skin areas without disrupting the skin's natural microbial balance.

[0050] Preferred Examples: Liposome-encapsulated tea tree oil, providing antimicrobial benefits without irritation, and other natural antimicrobials like neem oil or silver nanoparticles.

[0051] Other Examples: Liposome-Encapsulated Tea Tree Oil, Neem Oil, SilverNanoparticles, Benzoyl Peroxide, Triciosan (for use where regulations allow),Thyme Extract, Honey, Grapefruit Seed Extract, Benzalkonium Chloride,Salicylic Acid.

[0052] Barrier-Forming Agents

[0053] Purpose: To create a physical barrier on the skin, protecting against irritants and moisture loss. This category includes, but is not limited to, plant- derived squalane, which reinforces the skin’s lipid barrier for enhanced protection; beeswax, providing a natural protective layer on the skin's surface to prevent moisture loss; and silicone derivatives like dimethicone, which form a breathable barrier against environmental pollutants and irritants. Theseagents are carefully selected to strengthen the skin's defense mechanisms against external aggressors while maintaining skin breathability and comfort.

[0054] Preferred Examples: Plant-derived squalane, beeswax, or silicone derivatives like dimethicone, which can prevent irritation from friction and pressure.

[0055] Other Examples: Plant-Derived Squalane, Beeswax, SiliconeDerivatives (Dimethicone, Cyclomethicone), Petrolatum, Lanolin, Ceramides,Cholesterol, Shea Butter, Cocoa Butter, Mineral Oil.

[0056] Cooling and Soothing Agents

[0057] Purpose: To provide immediate relief from irritation and discomfort. This includes, but is not limited to, natural menthol derivatives that offer a cooling sensation to instantly relieve irritation; cucumber extract, rich in antioxidants and soothing properties to calm inflamed skin; and green tea extract, noted for its anti-inflammatory and antioxidant effects that protect and soothe the skin. These components are formulated to provide immediate relief from discomfort and reduce the appearance of irritation on the skin.

[0058] Preferred Examples: Natural menthol derivatives for a cooling effect, cucumber extract, and green tea extract, known for their soothing properties.

[0059] Other Examples: Natural Menthol Derivatives, Cucumber Extract, GreenTea Extract, Peppermint Oil, Calendula Extract, Witch Hazel, Aloe Vera Gel,Lavender Oil, Chamomile Extract, Allantoin.

[0060] Texture Enhancers and Stabilizers

[0061] Purpose: To ensure the cream has a pleasant feel, is easy to apply, and remains stable over time. This category includes, but is not limited to, chiaseed gel, which offers a unique texture and additional hydration benefits; xanthan gum, a natural polysaccharide that acts as an effective thickener and stabilizer; and acrylates / C10-30 alkyl acrylate crosspolymer, a synthetic polymer used to enhance the cream's texture and stability over time. These agents ensure the cream's pleasant feel, ease of application, and longevity.

[0062] Preferred Examples: Chia seed gel for a unique, smooth texture, xanthan gum, or acrylates / C10-30 alkyl acrylate crosspolymer for thickening and stabilizing the emulsion.

[0063] Other Examples: Chia Seed Gel, Xanthan Gum, Acrylates / C10-30 AlkylAcrylate Crosspolymer, Carbomer, Cetyl Alcohol, Stearyl Alcohol, Silicones(e.g., Dimethicone Crosspolymer), Cellulose Gum, Agar, Alginate.

[0064] Preservatives

[0065] Purpose: To maintain the shelf life of the cream. This includes, but is not limited to, natural preservative systems that combine the antioxidant and antimicrobial properties of compounds like ferulic acid with the skin- conditioning effects of ethylhexylglycerin, ensuring the formulation's safety and efficacy over its shelf life.

[0066] Preferred Examples: Natural preservative systems like combinations of ferulic acid and ethylhexylglycerin.

[0067] Other Examples: Ferulic Acid, Ethylhexylglycerin, Phenoxyethanol,Sodium Benzoate, Potassium Sorbate, Sorbic Acid, Caprylyl Glycol, BenzylAlcohol, Dehydroacetic Acid, Parabens (where regulations allow).

[0068] pH Adjusters

[0069] Purpose: To ensure it is safe for use on the skin by preventing microbial growth and maintaining a skin-friendly pH. This category includes, but is not limited to, lactic acid and citric acid, which are utilized not only to adjust the formulation's pH to a level compatible with the skin's natural pH but also to offer additional exfoliating and antioxidant benefits, respectively. These adjusters ensure the product's compatibility with the skin, enhancing its therapeutic effects.

[0070] Preferred Examples: pH adjusters such as lactic acid or citric acid to achieve an optimal pH for skin health.

[0071] Other Examples: Lactic Acid, Citric Acid, Sodium Hydroxide, PotassiumHydroxide, Sodium Lactate, Tartaric Acid, Malic Acid, Phosphoric Acid.

[0072] While there are various general-purpose dermatological creams and ointments available for skin irritation and rashes, they often lack the specificity and the combination of active ingredients necessary to address the multifaceted nature of wearable-induced skin conditions. For instance, common moisturizers might relieve dryness but do not provide the anti- inflammatory or antimicrobial protection needed. Similarly, anti-inflammatory creams might not offer the hydration or barrier protection required for prolonged wearable contact.

[0073] The present invention combines ingredients in a unique way that specifically targets the combination of symptoms associated with wearable technology use, such as irritation from friction, allergic reactions to materials, and moisture- related issues.

[0074] Some embodiments of the present invention utilize encapsulated hyaluronic acid microspheres for enhanced skin hydration represents an innovative approach within the context of treating wearable-induced skin conditions, ensuring deeper penetration and prolonged release.

[0075] The specific combination of plant-derived squalane, TasmanniaLanceolata extract, fermented bamboo extract, and other components allows for for multipronged action (hydration, anti-inflammation, antimicrobial, and cooling)

[0076] The advantages of this invention over existing products include:

[0077] Encapsulated Active Ingredients: Ensures deeper penetration and controlled release of active compounds for longer-lasting relief and protection.

[0078] Synergistic Formulation: Combines hydration, anti-inflammatory, antimicrobial, and cooling effects in one product, specifically targeting the unique challenges of wearable-induced skin conditions.

[0079] Plant-Derived and Natural Components: Offers a gentler alternative to chemical-heavy formulations, reducing the risk of further irritation or sensitization.

[0080] Innovative Texture and Application Experience: Utilizes chia seed gel for a unique, non-greasy texture that enhances user compliance and satisfaction.

[0081] The illustrations of embodiments described herein are intended to provide a general understanding of the structure of various embodiments, and they are not intended to serve as a complete description of ail the elements and features of apparatus and systems that might make use of the structuresdescribed herein. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description.

[0082] In recognition of the evolving landscape of dermatological science and the continuous innovation in skincare ingredients, this composition further claims the use of any chemical compounds, natural extracts, or synthetic derivatives that function to achieve the same therapeutic outcomes as those explicitly listed, including but not limited to hydration, inflammation reduction, microbial inhibition, skin barrier enhancement, and sensory relief. The scope of this claim encompasses not only the specific ingredients identified but also any future discoveries or developments that offer similar benefits through comparable mechanisms of action, alone or in combination. This includes novel bioactive compounds, next-generation polymers, and advanced encapsulation technologies designed to optimize the delivery, stability, and efficacy of active agents, thereby providing comprehensive protection and treatment of skin conditions induced or exacerbated by wearable devices. The claim extends to cover any such ingredients or combinations thereof that are developed with the intent to mimic, enhance, or otherwise replicate the therapeutic effects detailed herein, ensuring broad coverage against competitive formulations aiming to circumvent the novel and inventive aspects of this composition.

[0083] Furthermore, this patent claim extends to encompass all methods and technologies for the delivery of the active ingredients specified herein, as well as those achieving the claimed therapeutic effects, regardless of the delivery mechanism employed. This includes, but is not limited to, advanced delivery systems such as nanotechnology-based carriers, smart release systemscapable of responding to environmental or physiological triggers, and bioengineered constructs designed for enhanced penetration or targeted action within the skin layers. The claim covers the utilization of such technologies not only as they are currently understood but also includes any future developments or innovations that provide controlled, sustained, or targeted delivery of the composition's active agents to the skin, thereby ensuring effective treatment, alleviation, and prevention of conditions induced or exacerbated by wearable items. The scope herein is intended to preemptively include advancements in delivery technology that may offer improved bioavailability, efficacy, or user experience without departing from the core therapeutic objectives of the composition.

[0084] The wearable items the present invention refers to include, but are not limited to, a comprehensive range of devices and materials designed to be worn on or in close proximity to the skin, specifically tailored to address the diverse interactions between such wearables and the skin, including:

[0085] a. Electronic Devices: - Smartwatches and fitness trackers equipped with sensors that remain in constant contact with the skin, potentially causing irritation through friction, pressure, and sweat accumulation. -Health monitoring devices that may include components or adhesives that trigger allergic reactions or dermatitis in sensitive individuals. - Virtual reality headsets and augmented reality glasses that exert pressure on the face and around the eyes, areas particularly susceptible to irritation and acne mechanica.

[0086] b. Non-Electronic Items: - Jewelry made from metals that can cause contact allergies, such as nickel, cobalt, and chromium, requiring specific anti-inflammatory and barrier-protecting agents within the composition. - Clothing and accessories, including belts, straps, and undergarments, made from materials that may irritate the skin through dyes, latex, or other chemical treatments. - Orthopedic supports and medical devices that are worn for extended periods, where moisture and pressure can exacerbate skin conditions, highlighting the need for hydrating and barrier-forming agents.

[0087] c. Materials Used in Wearables: - Synthetic polymers and plastics found in bands and straps, which can cause occlusive conditions leading to acneiform eruptions and folliculitis. - Adhesives used in wearable patches and sensors that may induce irritant or allergic contact dermatitis, necessitating formulations that can soothe and heal the affected skin. - Textiles and fibers, especially those treated with waterrepellent or antimicrobial chemicals, which can disrupt the skin's microbiome or cause irritation, requiring a balanced antimicrobial strategy within the composition.

[0088] d. Future Innovations: - Anticipating advancements in wearable technology, including the development of bio-integrated devices, smart textiles with electronic functionalities, and wearables with prolonged battery life that may introduce new forms of skin irritation or sensitivity. - Consideration for emerging materials and manufacturing processes that could affect skin health, ensuring the composition remains effective against novel irritants and allergens.

[0089] Other embodiments may be utilized and derived from the present invention, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure.

[0090] Additionally, the composition accounts for the varying durations and conditions of wearable use, including:

[0091] Intermittent contact, such as with fitness trackers used only during exercise, which may increase sweat and friction.

[0092] Continuous wear, like smartwatches worn throughout the day and night, necessitating sustained hydration and protection.

[0093] Situational use in different environmental conditions, from dry indoor air to humid outdoor climates, requiring adaptable hydrating and barrier-forming capabilities.

[0094] The formulation is designed to be versatile, catering not only to the direct effects of wearables on the skin but also to the indirect consequences, such as changes in the skin's microbiome, heat and moisture retention, and the potential for UV light reflection and concentration by certain devices, enhancing the risk of photoaging and pigmentation.

[0095] Accordingly, the specification and drawings are to be regarded in an illustrative rather than a restrictive sense. Thus, although specific embodiments have been illustrated and described herein, it should be appreciated that any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments.

[0096] The present invention is specifically formulated for extensive dermatological use, characterized by its efficacy in treating, alleviating, and preventing a broad spectrum of skin conditions and reactions associated withor exacerbated by the wear of any type of wearable items, including, but not limited to:

[0097] a. Dermatitis of Various Forms: Including contact dermatitis arising from allergic reactions to wearable materials, atopic dermatitis exacerbated by friction or sweat accumulation under wearables, and seborrheic dermatitis influenced by occlusion or material irritation.

[0098] b. Eczema: Addressing both acute flare-ups and chronic conditions by providing moisture, reducing inflammation, and restoring the skin barrier function compromised by wearable-induced microenvironments.

[0099] c. Psoriasis: Alleviating symptoms such as itching and the appearance of red, scaly patches on skin areas under wearable devices, and preventing exacerbation due to pressure or trauma.

[0100] d. Contact Allergies: Preventing and treating skin reactions to specific materials found in wearables, ranging from metals and plastics to dyes and adhesives, through targeted action of anti-inflammatory and barrier-enhancing agents.

[0101] e. Skin Dryness and Dehydration: Providing deep hydration and enhancing the skin's ability to retain moisture, particularly in areas subject to prolonged contact with wearables that may disrupt the natural moisture balance.

[0102] f. Hyperpigmentation: Addressing discoloration and uneven skin tone that may result from inflammatory reactions to wearables, through ingredients that promote skin renewal and even pigmentation.

[0103] g. Photoaging: Protecting against and mitigating the effects of UV exposure exacerbated by wearable occlusion, through antioxidants and ingredients that support skin repair and resilience.

[0104] h. Sensitivity and Redness: Offering soothing relief and reducing the appearance of redness and sensitivity in skin areas affected by wearables, through gentle, calming ingredients.

[0105] i. Acne and Folliculitis: Treating and preventing breakouts and bacterial infections that can be aggravated by the occlusive environment created by wearables, through antimicrobial and pore-clearing agents.

[0106] j. Chafing and Friction-Related Conditions: Minimizing the risk and treating the effects of chafing and irritation caused by repetitive motion or tight- fitting wearables, with lubricating and skin-protecting agents.

[0107] Furthermore, the composition is designed for adaptability in response to emerging dermatological findings and advancements in wearable technology, ensuring ongoing relevance and applicability to new and evolving skin health challenges related to wearable use.

[0108] In anticipation of future scientific discoveries and advancements in the understanding of skin biology, microbiome interactions, and their implications for skin health, this patent claim expressly extends to include treatments, formulations, and methods that target newly identified pathways, mechanisms, or biological targets involved in skin conditions induced or exacerbated by wearable devices. This protection encompasses the application of novel active ingredients, unique combinations of known compounds, and innovative treatment methodologies that emerge from such advancements, providedthey aim to achieve the therapeutic objectives outlined herein. The scope of this claim is designed to be dynamically adaptable, ensuring comprehensive coverage against conditions related to wearables as the scientific community's knowledge of skin biology evolves. It includes, but is not limited to, advancements in understanding the skin's barrier function, immune responses, microbial flora balance, and genetic factors influencing skin reactions to external stressors, thereby preemptively securing rights to use such future discoveries in the composition's application for treating wearable-induced skin ailments.

[0109] Moreover, this patent encompasses the use and adaptation of the dermatological composition for a wide array of specific use cases, including niche markets and particular conditions associated with wearable technology not yet explicitly identified. This claim intends to cover any formulations developed for specialized applications or unique wearables-induced dermatological issues that emerge as the diversity of wearable devices expands. It includes, but is not limited to, targeted treatments for conditions discovered as a result of new wearable technologies, customized formulations for specific demographic groups or environmental conditions, and products designed for emerging health and wellness trends influenced by wearables.The scope of protection extends to formulations that, while potentially marketed for slightly different applications or use scenarios, fundamentally rely on the therapeutic principles and objectives outlined herein, ensuring comprehensive coverage against segment-specific innovations that may seek to address the same underlying skin health challenges presented by wearable devices.

[0110] The scope of this patent also includes formulations and methods specifically designed to address dermatological conditions associated with wearable technology use in ultra-specific demographic groups or populations defined by unique physiological, genetic, or environmental factors. This coverage extends to custom-tailored treatments that cater to the needs of such groups, ensuring that emerging niche markets or rare conditions exacerbated by wearable devices are inclusively protected under this patent.

[0111] Furthermore, this patent claim encompasses any future therapeutic targets or mechanisms of action discovered as a result of advancing scientific research into skin health and its interaction with wearable technologies. This includes innovative approaches that may not currently be known or understood but that offer potential for the treatment, alleviation, or prevention of conditions caused or aggravated by wearables, ensuring the patent's applicability to evolving therapeutic strategies.

[0112] In addition, this patent explicitly covers non-topical applications and interventions developed to mitigate the dermatological impact of wearable devices, including but not limited to ingestible products, devices directly interacting with the skin, and digital health solutions that contribute to skin health in the context of wearable technology use. This ensures that the patent's protection extends beyond traditional topical formulations to include a broad spectrum of innovative treatments and preventive measures.

[0113] Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description. Therefore, it is intended that the disclosure not be limited to the particular embodiment(s) disclosed.

Claims

What is claimed is:

1. A topical dermatologic preparation for treating wearable technology-induced skin irritation, comprising: one or more hydrating agents; one or more anti-inflammatory agents; one or more antimicrobial agents; one or more barrier-forming agents; one or more cooling and soothing agents; one or more texture enhancers and stabilizers; one or more preservatives; and one or more pH adjusters.

2. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1, wherein the preparation is one or more of a cream, lotion, gel, serum, spray, and / or a patch.

3. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1 , wherein the one or more hydrating agents are selected from the group comprising encapsulated hyaluronic acid microspheres, glycerin, and squalane.

4. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1, wherein the one or more anti-inflammatory agents are selected from the group comprising Tasmannia Lanceolata extract, aloe vera, and bisabolol (from chamomile).

5. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1 , wherein the one or more antimicrobial agents are selected from the group comprising liposome-encapsulated tea tree oil, neem oil and silver nanoparticles.

6. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1, wherein the one or more barrier-forming agents are selected from the group comprising squalane, beeswax, and silicone derivatives.

7. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1 , wherein the one or more cooling and soothing agents areselected from the group comprising menthol derivatives cucumber extract, and green tea extract.

8. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1, wherein the one or more texture enhancers and stabilizers are selected from the group comprising chia seed gel, xanthan gum, acrylates, andC10-30 alkyl acrylate crosspolymer.

9. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1 , wherein the one or more preservatives are selected from the group comprising ferulic acid and ethylhexylglycerin.

10. The topical dermatologic preparation for treating wearable technology-induced skin irritation of claim 1 , wherein the one or more pH adjusters are selected from the group comprising lactic acid and citric acid.

11. A method of treating wearable technology-induced skin irritation, comprising:determining an area of the body of a person on which a wearable device has been in contact; and applying a dermatologic preparation to an area of the body of a person on which a wearable device has been in contact.

12. A method of treating wearable technology-induced skin irritation, comprising: determining an area of the body of a person on which a wearable device has been in contact; and applying a dermatologic preparation according to claim 1 to an area of the body of a person on which a wearable device has been in contact.

Citation Information

Patent Citations

  • Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions

    US20100055138A1

  • Formulations with colloidal silver

    US20180235232A1

  • Compositions of silver and cannabinoids

    US20200171083A1

  • Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds

    US9629856B2